PA
SBBP

Perceptive Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

Perceptive Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-275,000
Closed -$1.65M – 144
2018
Q2 		$1.65M Hold
275,000
– – 0.04% 90
2018
Q1 		$2.43M Hold
275,000
– – 0.07% 92
2017
Q4 		$1.99M Buy
+275,000
New +$1.72M 0.07% 92

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
HCS
Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Perceptive Advisors's SBBP Position: Q3 2018 in Review

Perceptive Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2018, closing a stake of 275,000 shares — an estimated $1.65M sold.

Perceptive Advisors first reported a position in SBBP in Q4 2017 and held it in 3 quarters. The position peaked at $2.43M in Q1 2018. 49 funds tracked by Wall St. Rank hold SBBP as of Q3 2018.

  • Perceptive Advisors reported no remaining Strongbridge Biopharma plc. position as of Q3 2018 after selling out during the quarter.
  • Perceptive Advisors sold 275,000 Strongbridge Biopharma plc. shares in Q3 2018, an estimated $1.65M.
  • Perceptive Advisors first reported a position in Strongbridge Biopharma plc. in Q4 2017 and held it in 3 quarters.
  • Perceptive Advisors's Strongbridge Biopharma plc. position peaked at $2.43M in Q1 2018.
  • 49 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2018.

Based on Perceptive Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.